Aerts MB, Esselink RA, Abdo WF, Bloem BR, Verbeek MM (2012) CSF α-synuclein does not differentiate between Parkinsonian disorders. Neurobiol Aging 33:430.e1-430.e3. https://doi.org/10.1016/j.neurobiolaging.2010.12.001

Article  CAS  PubMed  Google Scholar 

Amin J, Erskine D, Donaghy PC, Surendranathan A, Swann P, Kunicki AP, Boche D, Holmes C, McKeith IG, O’Brien JT, Teeling JL, Thomas AJ (2022) Inflammation in dementia with Lewy bodies. Neurobiol Dis 168:105698. https://doi.org/10.1016/j.nbd.2022.105698

Article  CAS  PubMed  Google Scholar 

Anastassiadis C, Martinez-Valbuena I, Vasilevskaya A, Thapa S, Hadian M, Morales-Rivero A, Mora-Fisher D, Salvo C, Taghdiri F, Sato C, Moreno D, Anor CJ, Misquitta K, Couto B, Tang-Wai DF, Lang AE, Fox SH, Rogaeva E, Kovacs GG, Tartaglia MC (2024) CSF α-synuclein seed amplification assay in patients with atypical Parkinsonian disorders. Neurology 103(6):e209818. https://doi.org/10.1016/j.nbd.2022.10569810.1212/WNL.0000000000209818

Article  CAS  PubMed  Google Scholar 

Angelopoulou E, Paudel YN, Villa C, Piperi C (2020) Arylsulfatase A (ASA) in Parkinson’s disease: from pathogenesis to biomarker potential. Brain Sci. https://doi.org/10.3390/brainsci10100713

Article  PubMed  PubMed Central  Google Scholar 

Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548–560. https://doi.org/10.1001/jama.2019.22360

Article  PubMed  Google Scholar 

Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, Fox M, Goldstein JM, Soriano F, Seubert P, Chilcote TJ (2008) Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5:55–59. https://doi.org/10.1159/000112832

Article  CAS  PubMed  Google Scholar 

Bartl M, Dakna M, Schade S, Otte B, Wicke T, Lang E, Starke M, Ebentheuer J, Weber S, Toischer K, Schnelle M, Sixel-Döring F, Trenkwalder C, Mollenhauer B (2023) Blood markers of inflammation, neurodegeneration, and cardiovascular risk in early Parkinson’s disease. Mov Disord 38:68–81. https://doi.org/10.1002/mds.29257

Article  CAS  PubMed  Google Scholar 

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76:1035–1048. https://doi.org/10.1001/jamaneurol.2019.1534

Chang B, Gray P, Piltch M, Bulgin MS, Sorensen-Melson S, Miller MW, Davies P, Brown DR, Coughlin DR, Rubenstein R (2009) Surround optical fiber immunoassay (SOFIA): an ultra-sensitive assay for prion protein detection. J Virol Methods 159(1):15–22. https://doi.org/10.1016/j.jviromet.2009.02.019

Article  CAS  PubMed  Google Scholar 

Che N, Ou R, Li C, Zhang L, Wei Q, Wang S, Jiang Q, Yang T, Xiao Y, Lin J, Zhao B, Chen X, Shang H (2024) Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease. NPJ Parkinsons Dis 10(1):48. https://doi.org/10.1038/s41531-024-00664-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, Gu X, Wang X (2022a) α-synuclein in Parkinson’s disease and advances in detection. Clin Chim Acta 529:76–86. https://doi.org/10.1016/j.cca.2022.02.006

Article  CAS  PubMed  Google Scholar 

Chen WR, Chen JC, Chang SY, Chao CT, Wu YR, Chen CM, Chou C (2022b) Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson’s disease. Biomed J 45:914–922. https://doi.org/10.1016/j.bj.2021.12.010

Article  CAS  PubMed  Google Scholar 

Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L (2017) Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia. Alzheimers Res Ther 9:52. https://doi.org/10.1186/s13195-017-0276-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Concha-Marambio L, Pritzkow S, Shahnawaz M, Farris CM, Soto C (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18(4):1179–1196. https://doi.org/10.1038/s41596-022-00787-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Constantinides VC, Paraskevas GP, Emmanouilidou E, Petropoulou O, Bougea A, Vekrellis K, Evdokimidis I, Stamboulis E, Kapaki E (2017) CSF biomarkers beta-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes. J Neurol Sci 382:91–95. https://doi.org/10.1016/j.jns.2017.09.039

Article  CAS  PubMed  Google Scholar 

Constantinides VC, Majbour NK, Paraskevas GP, Abdi I, Safieh-Garabedian B, Stefanis L, El-Agnaf OM, Kapaki E (2021) Cerebrospinal fluid alpha-synuclein species in cognitive and movements disorders. Brain Sci 11:119. https://doi.org/10.3390/brainsci11010119

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, Wong DY, Duarte Folle A, Markovic D, Palma JA, Serrano GE, Adler CH, Perlman SL, Poon WW, Kang UJ, Alcalay RN, Sklerov M, Gylys KH, Kaufmann H, Fogel BL, Bronstein JM, Ritz B, Bitan G (2021) α-synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy. Acta Neuropathol 142:495–511. https://doi.org/10.1007/s00401-021-02324-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Estaun-Panzano J, Arotcarena ML, Bezard E (2023) Monitoring α-synuclein aggregation. Neurobiol Dis 176:105966. https://doi.org/10.1016/j.nbd.2022.105966

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M, Calabresi P, Parnetti L (2017) Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 32:1389–1400. https://doi.org/10.1002/mds.27110

Article  CAS  PubMed  Google Scholar 

Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MTM, Parkkinen L, Green AJE (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812–818. https://doi.org/10.1002/acn3.338

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandes Gomes B, Farris CM, Ma Y, Concha-Marambio L, Lebovitz R, Nellgård B, Dalla K, Constantinescu J, Constantinescu R, Gobom J, Andreasson U, Zetterberg H, Blennow K (2023) α-Synuclein seed amplification assay as a diagnostic tool for Parkinsonian disorders. Parkinsonism Relat Disord 117:105807. https://doi.org/10.1016/j.parkreldis.2023.105807

Article  CAS  PubMed  Google Scholar 

Førland MG, Tysnes OB, Aarsland D, Maple-Grødem J, Pedersen KF, Alves G, Lange J (2020) The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology. Eur J Neurol 27:43–50. https://doi.org/10.1111/ene.14032

Article  PubMed  Google Scholar 

Gautam G, Singh H (2024) Biomarkers in dementia research. In: Moradikor N, Chatterjee I, Mohamed W (eds) Nutrition in brain aging and dementia. Springer, Singapore, pp 93–107. https://doi.org/10.1007/978-981-97-4117-5_4

Gomes FP, Yates JR (2019) Recent trends of capillary electrophoresis-mass spectrometry in proteomics research. Mass Spectrom Rev 38(6):445–460. https://doi.org/10.1002/mas.21599

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goolla M, Cheshire WP, Ross OA, Kondru N (2023) Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers. Front Neurol 14:1210220. https://doi.org/10.3389/fneur.2023.1210220

Article  PubMed  PubMed Central  Google Scholar 

Guévremont D, Roy J, Cutfield NJ, Williams JM (2023) MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis. Sci Rep 13:16272. https://doi.org/10.1038/s41598-023-43096-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo T, Zhou L, Xiong M, Xiong J, Huang J, Li Y, Zhang G, Chen G, Wang Z-H, Xiao T, Hu D, Bao A, Zhang Z (2024) N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson’s disease. Aging Cell 23(5):e14124.